Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company’s $6 billion forecast
Moderna’s sales show the steep drop in demand for Covid products as cases and public concern about the virus dwindled front their pandemic peaks.
Second-largest U.S. radio company Audacy files for bankruptcy protection
Audacy, the radio and podcast giant, said Sunday it filed plans for Chapter 11 bankruptcy protection to reduce its debt.
Pentagon waited three days to inform White House that the defense secretary was hospitalized in ICU
Austin was hospitalized Jan. 1 after complications from an elective procedure.
Winter storm brings snow, sleet and rain to the Northeast
The system is expected to bring amounts of snow that major cities have not seen in several years.
Alaska Airlines grounds Boeing 737 Max 9 fleet after section blows out midair
Alaska Airlines will temporarily ground its fleet of 65 Boeing 737 Max 9 aircraft after a cabin panel blowout forced a jetliner to make an emergency landing.
Trump had meals at Jeffrey Epstein home, not massages, housekeeper testified
The name of Donald Trump was mentioned in court filings in a civil case related to Ghislaine Maxwell, the procurer for Jeffrey Epstein.
Coinbase is planning a pivotal acquisition that will allow it to launch crypto derivatives in the EU
Coinbase told CNBC exclusively that it entered into an agreement to buy an unnamed holding company which holds a Mifid II license.
Wayne LaPierre resigns as NRA leader, days before start of his civil trial
LaPierre and three other current and former NRA leaders are facing a lawsuit that alleges they violated nonprofit laws and misused NRA funds to finance their lavish lifestyles.
Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit
LillyDirect is the latest attempt to simplify what critics call a complex system for distributing, pricing and prescribing prescription drugs.
Florida wins first FDA approval to import cheaper drugs from Canada
Florida’s plan to import drugs from Canada will likely face hurdles before it takes effect, including potential lawsuits from the pharmaceutical industry.
